MBX Biosciences

MBX Biosciences

Advancing potential breakthrough medicines for endocrine diseases of substantial medical need.

Launch date
Employees
Market cap
€615m
Enterprise valuation
€565m (Public information from Sep 2024)
Carmel Indiana (HQ)
Authorizing premium user...